AM-0216

CAS No. 1202764-61-1

AM-0216( AM0216 )

Catalog No. M10737 CAS No. 1202764-61-1

AM-0216 (AM0216) is a highly potent inhibitor of NF-κB inducing Kinase (NIK).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AM-0216
  • Note
    Research use only, not for human use.
  • Brief Description
    AM-0216 (AM0216) is a highly potent inhibitor of NF-κB inducing Kinase (NIK).
  • Description
    AM-0216 (AM0216) is a highly potent inhibitor of NF-κB inducing Kinase (NIK), example 294 in patent WO 2009158011 A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AM0216
  • Pathway
    Apoptosis
  • Target
    NF-κB
  • Recptor
    NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1202764-61-1
  • Formula Weight
    363.439
  • Molecular Formula
    C19H17N5OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C#CC1=CC2=C(CCN2C3=NC(=NC=C3)N)C=C1)(C4=NC=CS4)O
  • Chemical Name
    (R)-4-(1-(2-aminopyrimidin-4-yl)indolin-6-yl)-2-(thiazol-2-yl)but-3-yn-2-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Henry KL, et al. Sci Signal. 2018 Jul 31;11(541). pii: eaam8216. 2. Example 294 in patent WO 2009158011 A1.
molnova catalog
related products
  • Eurycomalactone

    Eurycomalactone is a natural product isolated from Eurycoma longifolia Jack., acts as a potent NF-κB inhibitor( IC50 of 0.5 μM).?Eurycomalactone inhibits protein synthesis, depletes cyclin D1, but does not affect TNFα-induced degradation of IκBα or the phosphorylation of IKKα/β and IκBα.

  • Phyllanthin

    Phyllanthin is widely used as hepatoprotective and antigenotoxic and inhibit function of P-gp.

  • Tomatidine

    Tomatidine decreases inducible NO synthase and COX-2 expression through suppression of I-κBα phosphorylation, NF-κB nuclear translocation and JNK activation, which in turn inhibits c-jun phosphorylation and Oct-2 expression.